Publicaciones en las que colabora con Luis Sierrasesúmaga Ariznavarreta (8)

2015

  1. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 435-442

2005

  1. Pediatric meningosarcoma: Clinical evolution and genetic instability

    Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354

2004

  1. Methotrexate Pharmacokinetics and Survival in Osteosarcoma

    Pediatric Blood and Cancer, Vol. 42, Núm. 1, pp. 52-58

2002

  1. Pharmacodynamics of high-dose methotrexate in pediatric patients

    Annals of Pharmacotherapy, Vol. 36, Núm. 9, pp. 1344-1350

  2. Predicción del retraso en la eliminación de metotrexato mediante métodos bayesianos

    Farmacia Hospitalaria, Vol. 26, Núm. 2, pp. 90-95

2000

  1. Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24

  2. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites

    Cancer Genetics and Cytogenetics, Vol. 121, Núm. 1, pp. 78-85

1991

  1. DISMINUCION DEL ACLARAMIENTO DE METHOTREXATE A ALTAS DOSIS DESPUES DE CISPLATINO

    Oncologia, Vol. 14, Núm. 11, pp. 523-531